-
公开(公告)号:DE58905462D1
公开(公告)日:1993-10-07
申请号:DE58905462
申请日:1989-12-11
Applicant: HOECHST AG
Inventor: RUEGER WOLFGANG DR , URBACH HANSJOERG DR , RUPPERT DIETER DR , SCHOELKENS BERNWARD DR
IPC: A61K31/16 , A61K31/33 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4412 , A61K31/4418 , A61K38/00 , A61K38/55 , A61P9/12 , A61P31/12 , A61P43/00 , C07C291/02 , C07D213/81 , C07D233/64 , C07D295/18 , C07D333/24 , C07D521/00 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/065 , C07K14/81 , A61K37/64
Abstract: The present invention relates to compounds of the general formula I (I) in which A denotes a radical from the group comprising S, SO, SO2, O, CO, CS or a direct bond, B denotes the radical of an amino acid and D denotes a CH2 group or a radical -NR7-, where R7 can be hydrogen or a (C1-C4)alkyl radical; and in which R1 to R4 are defined as indicated in the description, to a process for the preparation thereof, to agents containing these, and to the use thereof.
-
公开(公告)号:BR9202325A
公开(公告)日:1993-01-19
申请号:BR9202325
申请日:1992-06-19
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER DR , HENNING RAINER DR , URBACH HANS JOERG DR , RUPPERT DIETER DR , LINZ WOLFGANG DR
IPC: A61K31/33 , A61K31/415 , A61K31/445 , A61K31/495 , A61K31/535 , A61P9/00 , A61P9/12 , A61P31/12 , A61P43/00 , C07D213/30 , C07D213/40 , C07D401/12 , C07D401/14 , C07D413/14 , C07D417/14 , C07D213/00 , C07D413/00 , C07D401/00 , C07D417/00
Abstract: Compounds of the formula (I) in which X and Y are, for example, N, R , R and R are, for example, hydrogen, A and L are, for example, CH2 or CO, Z is, for example, hydrogen, R is, for example, cyclohexylmethyl, R is, for example, hydroxyl, R is, for example, n is, for example, zero or 1, are active renin-inhibiting compounds which have a high in-vitro and in-vivo activity.
-
33.
公开(公告)号:CZ190692A3
公开(公告)日:1993-01-13
申请号:CS190692
申请日:1992-06-19
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER DR , HENNING RAINER DR , URBACH HANSJORG DR , RUPPERT DIETER DR , LINZ WOLFGANG DR
IPC: A61K31/33 , A61K31/415 , A61K31/445 , A61K31/495 , A61K31/535 , A61P9/00 , A61P9/12 , A61P31/12 , A61P43/00 , C07D213/30 , C07D213/40 , C07D401/12 , C07D401/14 , C07D413/14 , C07D417/14
Abstract: Compounds of the formula (I) in which X and Y are, for example, N, R , R and R are, for example, hydrogen, A and L are, for example, CH2 or CO, Z is, for example, hydrogen, R is, for example, cyclohexylmethyl, R is, for example, hydroxyl, R is, for example, n is, for example, zero or 1, are active renin-inhibiting compounds which have a high in-vitro and in-vivo activity.
-
公开(公告)号:CS9001980A2
公开(公告)日:1991-08-13
申请号:CS198090
申请日:1990-04-20
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , URBACH HANSJORG DR , RUPPERT DIETER DR , LINZ WOLFGANG DR , SCHOLKENS BERNWARD PROF DR
IPC: A61K38/55 , A61K38/00 , A61P9/00 , A61P9/12 , C07K1/06 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/065 , C07K14/81 , C07K5/08
CPC classification number: C07K5/06078 , A61K38/00 , C07K5/0227
-
公开(公告)号:CS9001979A2
公开(公告)日:1991-08-13
申请号:CS197990
申请日:1990-04-20
Applicant: HOECHST AG
Inventor: NICKEL WOLF-ULRICH DR , LINZ WOLFGANG DR , RUPPERT DIETER DR , URBACH HANSJORG DR , WAGNER ADALBERT DR
IPC: A61K38/55 , A61K38/00 , A61K38/05 , A61P9/12 , C07K1/06 , C07K1/113 , C07K5/06 , C07K5/065 , C07K14/81 , C07K7/00
CPC classification number: C07K5/06078 , A61K38/00
-
公开(公告)号:DE3924506A1
公开(公告)日:1991-01-31
申请号:DE3924506
申请日:1989-07-25
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , URBACH HANSJOERG DR , WAGNER ADALBERT DR , RUPPERT DIETER DR , LINZ WOLFGANG DR , KRAMER WERNER DR
IPC: C07C237/08 , C07C237/22 , C07D233/54 , C07D401/12 , C07D403/12 , C07D409/12 , C07K5/065 , C07K5/078
Abstract: Peptide polyhydroxyalkylamides of formula (I) and their salts are new; where A = R1R6N-CHR5-CO-, R1R7CH-CHR5-CO- or R1O-CHR5-CO-; R1 = R'1 or R'1W; R'1 = (a) 3-8C cycloalkyl, CONH2, OCH2COOH, NH2, etc. (b) H, OH or 1-4C alkoxy, (c) 1-18C alkyl, quanidino, phenyl(1-4C)alkoxy, etc. (d) 6-14C aryl, (6-14C)aryl(1-4C)alkyl, etc. (e) Het or Het(1-4C)alkyl, where Het is an opt. benzo-fused 5- to 7-membered heterocyclic ring contg. 1 or 2 of N, O, S, No, etc. (f) NR8R9; Het or Het(1-4C)alkyl, or NR8R9 is a mono- or bicyclic 5- to 12-membered ring system opt. contg. 1 or 2 more N atoms, an S atom or an O atom, opt. substd. by 1-4C alkyl; W = CO, CS, OSO, SO2, SO, NHSO2, NHCO, CHOH or NOH; n = 2-10.
-
公开(公告)号:DE3842067A1
公开(公告)日:1990-06-21
申请号:DE3842067
申请日:1988-12-14
Applicant: HOECHST AG
Inventor: RUEGER WOLFGANG DR , URBACH HANSJOERG DR , RUPPERT DIETER DR , SCHOELKENS BERNWARD DR
IPC: A61K31/16 , A61K31/33 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4412 , A61K31/4418 , A61K38/00 , A61K38/55 , A61P9/12 , A61P31/12 , A61P43/00 , C07C291/02 , C07D213/81 , C07D233/64 , C07D295/18 , C07D333/24 , C07D521/00 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/065 , C07K14/81
Abstract: The present invention relates to compounds of the general formula I (I) in which A denotes a radical from the group comprising S, SO, SO2, O, CO, CS or a direct bond, B denotes the radical of an amino acid and D denotes a CH2 group or a radical -NR7-, where R7 can be hydrogen or a (C1-C4)alkyl radical; and in which R1 to R4 are defined as indicated in the description, to a process for the preparation thereof, to agents containing these, and to the use thereof.
-
公开(公告)号:DE3841732A1
公开(公告)日:1990-06-13
申请号:DE3841732
申请日:1988-12-10
Applicant: HOECHST AG
Inventor: NICKEL WOLF-ULRICH DR , URBACH HANSJOERG DR , RUPPERT DIETER DR , SCHOELKENS BERNWARD PROF DR
IPC: C12N9/99 , A61K38/00 , A61K38/05 , A61K38/55 , A61P9/12 , A61P31/12 , C07D277/42 , C07K1/02 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/065 , C07K14/81
Abstract: Compounds of the formula I in which R is (subst.) heterocyclyl-alkyl, -alkoxy, -cycloalkyl, -cycloalkoxy and the corresponding heterocyclylmercapto compounds, A and B are, independently of one another, an amino acid, R is hydrogen, alkyl, cycloalkyl, cycloalkyl-alkyl, aryl or aryl-alkyl, R is hydrogen, alkyl, aryl, aryl-alkyl or hydroxyl, and R is a radical (CH2)0-4CHR -D, with R = hydrogen, alkyl, alkoxy, alkylthio, alkylamino, hydroxyl, azido or halogen and D = (subst.) heterocyclyl, have enzyme-inhibiting properties. Processes for preparing compounds of the formula I and the use thereof for treating high blood pressure and viral diseases are described.
-
公开(公告)号:DE3627877A1
公开(公告)日:1988-02-04
申请号:DE3627877
申请日:1986-08-16
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , KLEEMANN HEINZ-WERNER DR , RUPPERT DIETER DR , SCHOELKENS BERNWARD DR
IPC: A61K31/415 , A61K38/00 , C07D233/54 , C07D233/64 , C07K1/00 , C07K5/02 , C07K5/06 , C07K5/065 , C07K5/08 , A61K37/02 , A61K37/64
Abstract: The invention relates to compounds of the formula in which R1 is absent or denotes hydrogen, alkyl or acyl, A denotes an acyl radical or an amino acid residue, B denotes an amino acid residue, and R2, R3 and R4 are as defined in the specification, and to their salts, to a process for their preparation, to pharmaceutical products containing them, and to their use as medicaments, and intermediates for the preparation of these compounds.
-
公开(公告)号:DE4422911A1
公开(公告)日:1996-01-04
申请号:DE4422911
申请日:1994-06-30
Applicant: HOECHST AG
Inventor: PEYMAN ANUSCHIRWAN DR , STAHL WILHELM DR , BUDT KARL-HEINZ DR , RUPPERT DIETER DR , SCHUESLER HENNING , WAGNER KONRAD
IPC: A61K31/675 , A61P31/12 , C07F9/6584
Abstract: Cyclic phosphinic acid derivs. of formula (I) are new: A = gp. of formulae (a) or (b); n = 0 or 1; Y, R = O or S; R = H, alkyl, alkenyl, etc.; R , R * = H, NH2, alkyl, etc.; or R +R * = 3-6 membered ring opt. contg. 1-3 heteroatoms, e.g. O or N; G, F = H, F, Cl, Br, OH or R ; but F = H when G = OH; R = H, 1-20C acyl, or OH pro-drug gp.; B = e.g. -C(L)-; L = e.g. O; D, D* = H, 1-20C Alk , R or R -(1-6C Alk ); Alk = satd., mono- or multiply-unsatd. or cyclic alkyl, etc.; R = satd., unsatd. or partly unsatd. 3-35C isocyclic or heterocyclic ring system contg. 3-9 membered rings, etc.; E, E* = H, satd. or unsatd. 1-7C alkyl opt. mono-, di- or tri-substd. by F, Cl, Br or 1-3C alkoxy, etc..
-
-
-
-
-
-
-
-
-